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Abstract
Flecainide is a class Ic anti - arrhythmic drug with sodium channel blocking activities. We report a
case of a 57 year - old woman who attempted a suicide by ingesting approximately 1,8 gr of
flecainide. On the surface electrocardiogram this results in a large QRS complex and in
prolongation of the QTc interval. Overdose with a class Ic drug is very uncommon, its management
is difficult and the mortality high.
Because of a hemodynamic instability and in addition to supportive care and antidysrhythmics, she
was treated with a high dose of sodium bicarbonate in hypertonic solution; after this infusion the
patient's QRS progressive narrowed.
In conclusion, sodium bicarbonate may be useful in the treatment of widened QRS and to stabilize
a overdose of class Ic anti - arrhythmic drugs.
Introduction
Flecainide is a Vaughn - Williams class IC antiarrhtythmic
agent used for the treatment of supra - ventricular and,
also, ventricular arrhythmias.
In some countries, such as United states, its use is limited
because of known proarrhytmic effects [1]. Chemically, it
causes a rate - dependent slowing of a rapid sodium chan-
nels slowing phase of depolarisation [2]. Flecainide, also,
slows conduction in all cadiac fibres, increasing conduc-
tion times in the atria, ventricles, atrio - ventricular node
and his - Purkinje system and can cause myocardial
depression. Flecainide is cleared mainly by the liver at a
relatively high rate (5,6 ml/kg per minute) but its large
value of distribution (4,9 ml(kg)) yields a large half - life
of 11 hours [3]. Oral loading - dose 50 of flecainide is 50
- 498 mg/kg in rat; it is extensively metabolized mainly to
m - O - dealkylated flecainide and the m - O - dealkylated
lactam of flecainide; the first makes up to 20% of the
drug's anti - arrhythmic activity. Furthermore flecainide is
excreted mainly in urine (about 10 to 50% as the
unchanged drug and the remainder as metabolites,
depending on type of administration; about 5% is
excreted in faeces).
Flecainide is a rare cause of suicide attempt by drug over-
dose; furthermore there are not specific antidote and no
way of rapidly eliminating the drug from the body [4].
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Commonly recommended therapies, including haemodi-
alysis (in this case we can remove only 1% of unchanged
flecainide), treatment with hypertonic saline solution and
pacing, have not been shown to improve survival.
In the literature we find also some anecdotal case report of
particularly therapy used to treat flecainide overdose. Tim-
perly et al [5], in 2005, reported a case complicated by car-
diogenic shock and treated with pharmacological
inotropic support and intra - aortic balloon pump; in 48
hours both QRS and ventricular function had returned to
normality.
Yasui et al [6], described, in a young woman, another pos-
sible approach such as peripheral cardiopulmonary
bypass support (CBS) to maintain perfusion of the liver;
this CBS successfully supported the patient until flecain-
ide level decreased as a result of redistribution and normal
clearance mechanisms.
We report a case of flecainide poisoning which was suc-
cessfully treated with high dose of sodium bicarbonate in
hypertonic solution.
Case report
A 57 year - old women with a history of previous supra -
ventricular tachyarrhythmia and chronic therapy with fle-
cainide acetate (100 mg every day) without any cardiovas-
cular risk factors, was admitted to our Emergency -
Department having ingested 18 tablets of flecainide ace-
tate (equivalent to approx 1,8 gr) for a suicide attempt.
On admission she was responsive and conscious; pulse
was 90 bpm and blood pressure 110/70 mmHg.
The first electrocardiogram (EKG) showed a sinusal
rhythm with a large QRS complex (similar to a right blun-
dle branch block) and a very long QT tract (about 500
msec.) (Figure 1).
The patient was carried into our Intensive Care Unit (ICU)
and initially treated with oxygen and intravenous crystal-
loids. The results of the first arterial blood analysis were
PH 7,472, PCO2 41,2 mmHg, PO2 130 mmHg (oxygen 4
l/minutes non invasive), HCO 29,8 ng/l. The hemato-
chemical parameters were: K+ 3,5 mmol/l, Na+ 143 mmol/
l, Cl- 103 mmol/l. Flecainide serum levels after 30 minutes
from admission were 1940 μg/ml (therapeutic range are
200 - 1000 μg/ml).
Furthermore a therapy with instillation of 40 mg of acti-
vated charcoal and 40 mg of MgSO4 was started. Approxi-
mately 45 minutes after admission to our ICU the poison
Centre of "San Matteo Hospital" at Pavia (far off 60 Km)
was contacted; they suggested bolus of sodium bicarbo-
nate (NaCO3) 150 mEq and NaCO3 130 mEq in slow
infusion (1 - 2 MEq/h) for 24 Hours.
Flecainide serum levels 6 hours after the beginning of this
infusion were 990 μg/ml
Good progress were made over the next 72 hours and no
signs of organ dysfunction were evident. None were
apparent and the EKG had returned to normality and a
psychiatric referral was made (Figure 2). The serum con-
centration of flecainide progressively returned to normal
(Figure 3) and four days after the overdose the patient was
transferred to medical ward and after other three days she
was discharged to home.
The first electrocardiogram with a large QRS complex and a  very long QTc interval Figure 1
The first electrocardiogram with a large QRS com-
plex and a very long QTc interval.
The pre - discharge electrocardiogram Figure 2
The pre - discharge electrocardiogram.Cases Journal 2009, 2:9137 http://www.casesjournal.com/content/2/1/9137
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Discussion
As far as we are aware, there are no previously reported
cases of high dose of sodium bicarbonate being used to
treat acute flecainide overdose. This drug is a class Ic anth-
yarrhythmic agent which acts by blocking sodium chan-
nels involved in cardiac depolarization; this results in
marked suppression of the cardiac conduction system in
addition to a moderate negative inotropic effect [7]. All
these actions are manifest on the EKC by increased lenght
of PR, QRS and QTc intervals.
The pharmacokinetics qualities of flecainide are high oral
bioavaibility of 95% elimination, half - life seems variable
with a quarter of the drug undergoing renal excretion
unchanged [8] the remainder undergoes hepatic metabo-
lism to inactive derivates.
The therapeutic range of flecainide is considered to be 200
- 1000 μg/ml. In a toxic flecainide overdose, adverse car-
diac effects including bradycardia, atrio - ventricular
block, pulse less electrical activity and asystole can occur
within 30 to 120 minutes of ingestion [9]. Treatment
should be direct at decreasing gastrointestinal absorption
through gastric emptying and administration of activate
charcoal[9]; furthermore serum flecainide levels should
be reduced through maintenance of organs perfusion
which allows drug clearance and distribution.
In the literature many proarrhythmic effects of flecainide
are described; they may be related to its promoting re -
entry in ventricular issue [9].
Worsening of existing ventricular arrhythmias or the onset
of ones can occur in up to 30% of patients [10]
Because type Ic drugs such as flecainide produce both
therapeutic and toxic effects due to extensive rate -
dependent sodium channel - blockade in the myocar-
dium, attempt to treat toxicity with hypertonic sodium
bicarbonate or molar lactate have been attempted in ani-
mals [11] and in humans [8,9,12] with mixed success.
Keyler et al [11] showed, in rats treated with 6 mEq/kg of
hypertonic sodium bicarbonate, reduced to 26% flecain-
ide induced QRS prolongation. Like - wise, 5 mEq/kg of
hypertonic sodium bicarbonate in dogs resulted in signif-
icant shortening of the QRS and his - ventricular intervals
within 10 minutes [13]. Furthermore the same authors
reported that of in dogs with pacing - induced dysarrhyth-
mias after flecainide administration, 6 of 7 responded to
hypertonic sodium bicarbonate, with only 1 of 7 respond-
ing to placebo[13]. Hypertonic sodium bicarbonate and
sodium clorate work by increasing the extra cellular con-
centration of sodium displacing flecainide from its recep-
tors sites either inside the selectivity filter of the fast
sodium channels or at on external anaesthetic receptors
site [14].
Because flecainide is a weak acid with a high pKa, alkali-
nization may also decrease the active - ionized fraction of
flecainide necessary for sodium channels blockade.
Chouty et al [15] used doses of 500 mL of 1 M sodium lac-
tate endovenous for more than 30 minutes to treat three
cases of flecainide poisoning with rapid narrowing of the
QRS interval and correction of hypotension, and another
flecainide overdose responded to combination to a com-
bination of 250 mmol of hypertonic sodium bicarbonate,
136 mmol NaCl and physostigmine 2 mg endovenous in
the report of Wilkelman [9].
Our patient's dysarrhythmia did not resolve until sodium
bicarbonate was administered.
All our observations suggest that sodium bicarbonate may
be useful for the treatment of widened QRS and ventricu-
lar ectopy resulting from flecainide toxicity.
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Flecainide levels during hospitalization Figure 3
Flecainide levels during hospitalization.
0
500
1000
1500
2000
2500
123456
Hours
F
l
e
c
a
i
n
i
d
e
 
μ
g
/
m
lPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cases Journal 2009, 2:9137 http://www.casesjournal.com/content/2/1/9137
Page 4 of 4
(page number not for citation purposes)
References
1. Roden DM, Woosley RL: Drug therapy: Flecainide.  N Engl J Med
1986, 315:36-41.
2. Wang Z, Fermini B, Nattel S: Mechanism of flecainide's rate -
dependet actions on action potential duration in canine
atrial tissue.  J Pharmacol Exp Ther 1992, 267(2):575-581.
3. Funck-Brentano C, Becquemont L, Kroemer HK, Bühl K, Knebel NG,
Eichelbaum M, Jaillon P: Variable disposition kinetics and elec-
trocaridographic effects of flecainide during repeated dosing
in humans: contribution of genetic factors, dose - dependent
clearance, and interaction with amiodarone.  Clin Pharmacol
Ther 1994, 55:256-269.
4. Siegers A, Board PN: Amiodarone used in successful resuscita-
tion after near - fatal flecainide overdose.  Resuscitation 2002,
53:105-108.
5. Timperly J, Mitchell ARJ, Brown PD, West NEJ: Flecainide over-
dose - support using an intra - aortic balloon pump.  BMC
emergency Medicine 2005, 5:10.
6. Yasui RK, Culclasure TF, Kaufman D, Freed CR: Flecainide Over-
dose: Is Cardiopulmonary Support the treatment?  Annals of
Emergency Medicine 1997, 29:680-682.
7. Bourke JP, Cowan JC, Tansuphaswadikul S, Campbell RWF:
Antiarrhythmic drug effects on left ventricular performance.
Eur Heart J 1987, 8(Suppl A):105-111.
8. Koppel C, Oberdisse U, Heinemeyer G: Clinical course and out-
come in class Ic antiarrhythmic overdose.  Clin toxicol 1990,
28:433-444.
9. Winkelmann BR, Leinberger H: Life - threatening toxicity: A
pharmacodynamic approach.  Ann Intern Med 1987, 106:807-814.
10. Gotz D, Pohle S, Freed CR: Extracorporeal pump assistance:
novel treatment for acute lidocaine poisoning.  Eur J Clin Phar-
macol 1982, 22:129-135.
11. Keyler DE, Pentel PR: Hypertonic sodium bicarbonate partially
reverses QRS prolongation due to flecainide in rats.  Life Sci
1989, 264:1575-1580.
12. Pentel PR, Goldsmith SR, Salerno DM, Nasraway SA, Plummer DW:
Effect of hypertonic sodium bicarbinate on encainamide
overdose.  Am J Cardiol 1986, 57:878-880.
13. Bajaj AK, Woosley RL, Roden DM: Acute electrophysiologic
effects of sodium bicarbonate administration in dogs treated
with O - desmethyl encainide.  Circulation 1989, 80:994-1002.
14. Ranger S, Sheldon R, Femrini B, Natttel S: Modulation of flecain-
ide's cardiac sodium channel blockade actions by extra cellu-
lar sodium: a possible cellular mechanism for the action of
sodium salts in flecainide cardiotoxicity.  J Pharmacol Exp Ther
1993, 264:1160-1167.
15. Chouty F, Funck-Brentano C, Landau JM, Lardoux H: Effectiveness
of intravenous high dose molar lactate in flecainide poison-
ing.  Presse Med 1987, 16:808-810.